Page 163 - CW E-Magazine (6-5-2025)

News from Abroad

approximately $6-billion in near term we expect to receive greater than $1-bn worldwide are awaiting additional clarity
cash support. First, we are on track to in proceeds from the Nova judgment into how the tariff and global trade
close Dow’s sale of a minority stake in this year. Additionally, our decision to negotiations will land. In the meantime,
select U.S. Gulf Coast infrastructure delay our Path2Zero project in Alberta, we remain focused on managing a disci-
assets by May 1. This strategic move Canada will result in a total reduction plined and balanced capital allocation
to create a new infrastructure-focused of $1-bn in enterprise capex spending approach over the cycle. These collec-
entity has been several years in the mak- this year. And lastly, we remain com- tive actions help to ensure Dow’s finan-
ing, and is expected to generate pro- mitted to delivering at least $1-bn in cial flexibility and our long-term com-
ceeds of up to $3-bn in 2025. Second, targeted cost savings by 2026. Markets petitiveness.”

OPTIMISING FOOTPRINT
DyStar to stop operations at another US site

Singapore-headquartered textile
chemicals firm, DyStar, has announced
further consolidation of its US manu-
facturing footprint with cessation of
manufacturing operations at its Dy-
Star Hilton Davis facility in Cincinatti,
Ohio. Some part of the production
at Ohio will be integrated within its
existing operations in Reidsville, North
Carolina.

The Ohio facility primarily manu-
factures dyes for the food, drug, and
cosmetic sector as well as lakes, techni-
cal dyes and pigment dispersions. housing its facility in Charlotte, Mr. Xu Yalin, Managing Director
Carolina, and subsequent consolida- and President, DyStar Group said, “We
“As part of our ongoing efforts to tion its activities at Reidsville, North believe that the success of the strategic
consolidate and optimise our manufac- Carolina. plan will position DyStar to decisively
turing footprint in Americas, the faci- respond to the fundamental changes
lity will cease production operations on DyStar said the Group’s consoli- taking place in the industry and enables
30 June 2025,” the company informed. dation plan has been completed and us to improve profitability while main-
its Americas production activities will taining strategic product development
In February this year, DyStar had be focused at sites in Reidsville, North capability, and to accelerate growth
announced the sale of the property Carolina, and Cheyenne, Wyoming. over the long-term.”

ICL to acquire most activities of Evogene subsidiary, Lavie Bio

Isreal’s speciality minerals and ferti- ICL include Lavie Bio’s core team, rate future revenue for Lavie Bio’s
liser firm, ICL, has inked a deal with the BDD technology platform, the shareholders.
Evogene, a US-based computational company’s microbial bank and data
biology company, to acquire the majo- assets, the majority of the compa- This transaction follows stra-
rity of activity of Evogene’s subsidiary, ny’s development programs, and tegic investment by ICL Planet
Lavie Bio Ltd. Lavie Bio is a leader its commercial products. Addition- and more than two years of colla-
in the ag-biologicals industry with a ally, ICL will acquire Evogene’s boration between ICL and Lavie
robust pipeline of microbiome-based MicroBoost AI for AG platform. Bio, focused on developing inno-
ag-biological products. Lavie Bio’s existing agreements vative bio-stimulant solutions for
with its current partners will not be row crops facing various abiotic
Key assets to be transferred to transferred to ICL and may gene- stresses.

Chemical Weekly May 6, 2025 163

Contents Index to Advertisers Index to Products Advertised